Published November 24, 2020
| Version v1
Journal article
Open
Multisystem Inflammatory Syndrome in Children: An International Survey
Authors/Creators
- 1. Paediatric Cardiology Services, Royal Brompton Hospital, London, United Kingdom;; National Heart and Lung Institute and; Contributed equally as co-first authors
- 2. Department of Pediatric Cardiology, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Spain;; Department of Critical Care Medicine, University of Pittsburg Medical Center Children's Hospital of Pittsburgh and University of Pittsburgh, Pittsburgh, Pennsylvania;; Contributed equally as co-first authors
- 3. Division of Cardiology, Children's Hospital at Montefiore, New York, New York;; Department of Pediatrics, Albert Einstein College of Medicine, New York, New York;
- 4. Department of Paediatrics, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom;; Section of Paediatric Infectious Diseases, Department of Infectious Diseases, Imperial College London, London, United Kingdom;
- 5. M3C-Necker Enfants Malades, Assistance Publique–Hôpitaux de Paris, Paris, France;; Université de Paris, Paris, France;
- 6. Department of Pediatric Cardiology, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Spain;
- 7. Department of Pediatric Cardiology, Hospital Universitario La Paz, Madrid, Spain;
- 8. Paediatric Cardiology Services, Royal Brompton Hospital, London, United Kingdom;; National Heart and Lung Institute and
- 9. Cardiology Care for Children, Lancaster, Pennsylvania;
- 10. Cardiac Critical Care Medicine, Children's National Hospital, Washington, District of Columbia;
- 11. AOU Ospedali Riuniti, Ancona, Italy;
- 12. NICU, Cambridge University Hospitals, Cambridge, United Kingdom; and; School of Clinical Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom
Description
OBJECTIVES:
To describe presentation, hospital course, and predictors of bad outcome in multisystem inflammatory syndrome in children (MIS-C).
METHODS:
Retrospective data review of a case series of children meeting the published definition for MIS-C who were discharged or died between March 1, 2020, and June 15, 2020, from 33 participating European, Asian, and American hospitals. Data were collected through a Web-based survey and included clinical, laboratory, electrocardiographic, and echocardiographic findings and treatment management.
RESULTS:
We included 183 patients with MIS-C: male sex, 109 (59.6%); mean age 7.0 ± 4.7 years; Black race, 56 (30.6%); obesity, 48 (26.2%). Overall, 114 of 183 (62.3%) had evidence of severe acute respiratory syndrome coronavirus 2 infection. All presented with fever, 117 of 183 (63.9%) with gastrointestinal symptoms, and 79 of 183 (43.2%) with shock, which was associated with Black race, higher inflammation, and imaging abnormalities. Twenty-seven patients (14.7%) fulfilled criteria for Kawasaki disease. These patients were younger and had no shock and fewer gastrointestinal, cardiorespiratory, and neurologic symptoms. The remaining 77 patients (49.3%) had mainly fever and inflammation. Inotropic support, mechanical ventilation, and extracorporeal membrane oxygenation were indicated in 72 (39.3%), 43 (23.5%), and 4 (2.2%) patients, respectively. A shorter duration of symptoms before admission was found to be associated with poor patient outcome and for extracorporeal membrane oxygenation and/or death, with 72.3% (95% confidence interval: 0.56–0.90; P = .006) increased risk per day reduction and 63.3% (95% confidence interval: 0.47–0.82; P < .0001) increased risk per day reduction respectively.
CONCLUSIONS:
In this case series, children with MIS-C presented with a wide clinical spectrum, including Kawasaki disease–like, life-threatening shock and milder forms with mainly fever and inflammation. A shorter duration of symptoms before admission was associated with a worse outcome.
Files
fulltext.pdf
Files
(753.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:a4b4222a8fbc0910699911c3e6d4485e
|
753.2 kB | Preview Download |